~~<i id='CA7DC8CCE7'><strike id='CA7DC8CCE7'><tt id='CA7DC8CCE7'><pre id='CA7DC8CCE7'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：entertainment 2025-10-02 06:36:10 Page View：819

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How redistricting in 6 states could affect who controls Congress
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

Wikipedia

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

The inclusion problem at the heart of rehabilitation research

JamesSulzerwithhisdaughterLivie.LindsaySulzerInthespringof2020,myalmost4-year-olddaughterLiviesustai

How to save PrEP access — and even expand it

UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

Rare Northern Lights show in US this week: Where and how to see it

1:14Anauroraborealis,alsoknownasthenorthernlights,isseeninthenightskyintheearlymorninghoursofApril24